![](/img/cover-not-exists.png)
D04Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer
Lonardi, S., Cohn, A.L., Yoshino, T., Obermannova, R., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., Garcia-Alfonso, P., Portnoy, D.C., Van Cutsem, E., Yamazaki, K., Clingan, P.R., PolVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw335.04
Date:
September, 2016
File:
PDF, 45 KB
english, 2016